BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24517320)

  • 1. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
    Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
    Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aprepitant for the Treatment of Chronic Refractory Pruritus.
    He A; Alhariri JM; Sweren RJ; Kwatra MM; Kwatra SG
    Biomed Res Int; 2017; 2017():4790810. PubMed ID: 29057261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of aprepitant in the management of pruritus in a patient with cutaneous T-cell lymphoma].
    Palacios Zabalza I; López de Torre Querejazu A; Santos Ibañez A
    Farm Hosp; 2014 Apr; 38(2):145-7. PubMed ID: 24669900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose.
    Muñoz M; Parrilla J; Rosso M; Coveñas R
    Acta Derm Venereol; 2019 May; 99(6):620-621. PubMed ID: 30734049
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypopigmented mycosis fungoides].
    Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
    Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic pruritus presenting with Hodgkin's lymphoma: a case report.
    Villafranca JJ; Siles MG; Casanova M; Goitia BT; Domínguez AR
    J Med Case Rep; 2014 Sep; 8():300. PubMed ID: 25200537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypopigmented mycosis fungoides. Speculations about the mechanism of hypopigmentation.
    Goldberg DJ; Schinella RS; Kechijian P
    Am J Dermatopathol; 1986 Aug; 8(4):326-30. PubMed ID: 3766921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.
    Ladizinski B; Bazakas A; Olsen EA
    J Am Acad Dermatol; 2012 Nov; 67(5):e198-9. PubMed ID: 23062910
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypopigmented mycosis fungoides.
    Handfield-Jones SE; Smith NP; Breathnach SM
    Clin Exp Dermatol; 1992 Sep; 17(5):374-5. PubMed ID: 1458652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
    Serrano L; Martinez-Escala ME; Zhou XA; Guitart J
    Dermatol Clin; 2018 Jul; 36(3):245-258. PubMed ID: 29929596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.
    Santini D; Vincenzi B; Guida FM; Imperatori M; Schiavon G; Venditti O; Frezza AM; Berti P; Tonini G
    Lancet Oncol; 2012 Oct; 13(10):1020-4. PubMed ID: 22995650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature.
    Stone ML; Styles AR; Cockerell CJ; Pandya AG
    Cutis; 2001 Feb; 67(2):133-8. PubMed ID: 11236223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypopigmented mycosis fungoides in a white female.
    Amichai B; Grunwald MH; Avinoach I; Halevy S
    J Dermatol; 1996 Jun; 23(6):425-6. PubMed ID: 8708157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides presenting as hypopigmented and pigmented purpura-like lesions: coexistance of two clinical variants.
    Kavala M; Zındancı I; Sudogan S; Can B; Turkoglu Z; Demırkesen C; Kural E
    Eur J Dermatol; 2011; 21(2):272-3. PubMed ID: 21421452
    [No Abstract]   [Full Text] [Related]  

  • 16. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.
    Song JS; Tawa M; Chau NG; Kupper TS; LeBoeuf NR
    BMC Cancer; 2017 Mar; 17(1):200. PubMed ID: 28302100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprepitant in the treatment of refractory pruritus secondary to cutaneous T-cell lymphoma.
    Borja-Consigliere HA; López-Pestaña A; Vidal-Manceñido MJ; Tuneu-Valls A
    Actas Dermosifiliogr; 2014 Sep; 105(7):716-8. PubMed ID: 24139470
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides.
    Khopkar U; Doshi BR; Dongre AM; Gujral S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):167-73. PubMed ID: 21393946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypopigmented mycosis fungoides in a 10-year-old boy.
    Manzur A; Zaidi ST
    Dermatol Online J; 2006 Oct; 12(6):21. PubMed ID: 17083901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprepitant as an antipruritic agent?
    Duval A; Dubertret L
    N Engl J Med; 2009 Oct; 361(14):1415-6. PubMed ID: 19797294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.